Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
NCT01386554
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Proteinuria
Idiopathic Membranous Nephropathy
Interventions
DRUG:
Repository Corticotropin Injection
DRUG:
Placebo
Sponsor
Mallinckrodt